探索血糖控制对糖尿病视网膜病变的影响:新兴模型和预后影响
Nicola Tecce1, Gilda Cennamo2,3, Michele Rinaldi2,3
1Unit of Endocrinology, Dipartimento di Medicina Clinica e Chirurgia, Federico II University Medical School of Naples, 80131 Napoli, Italy.
Journal of clinical medicine
|February 10, 2024
概括
这篇评论探讨了1型糖尿病 (T1D) 的并发症,如糖尿病视网膜病变 (DR). 先进的混合闭环系统 (HCLS) 和个性化算法显示出更好的糖尿病管理和结果的前景.
科学领域:
- 内分泌学和新陈代谢学
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
背景情况:
- 1型糖尿病 (T1D) 存在重大管理挑战,并与严重的并发症有关.
- 糖尿病视网膜病变 (DR),包括糖尿病黄斑,是一种主要的微血管并发症,由失糖症驱动.
- 目前的糖尿病管理策略需要进步,以减轻长期的健康风险.
研究的目的:
- 审查T1D及其并发症的复杂性,重点关注糖尿病视网膜病变.
- 突出糖尿病管理的技术进步,特别是混合闭环系统 (HCLS).
- 讨论开源HCLS和个性化算法的潜力,以改善患者的治疗结果.
主要方法:
- 文献综述侧重于T1D,糖尿病视网膜病变的发病,以及糖尿病技术.
- 对糖尿病视网膜病变从非增殖阶段到增殖阶段的进展进行分析.
- 评估混合闭环系统 (HCLS),包括开源适应和机器学习应用.
主要成果:
- 低血糖是糖尿病视网膜病变和糖尿病黄斑的致病的一个关键因素.
- 混合闭环系统 (HCLS) 代表了糖尿病管理的重大技术进步.
- 开源HCLS利用大数据和机器学习,为个性化糖尿病护理提供了潜力.
结论:
- 个性化HCLS算法整合生活方式,饮食和荷尔蒙数据对于减少T1D并发症至关重要.
- 糖尿病管理的技术创新,特别是HCLS,对于改善患者的治疗结果至关重要.
- 未来的方向强调适应性,数据驱动的方法,以有效地管理T1D和预防并发症.
关键词:
在Android应用程序中应用程序.这就是为什么DR DR DR DR先进的混合闭环系统 (AHCL)持续的葡萄糖监测 (CGM)糖尿病 (T1D) 是一种糖尿病.糖尿病管理 糖尿病管理流行病学流行病学机器学习是机器学习.微血管病的并发症 微血管病的并发症新血管化的新血管化.非扩散性DR (NPDR) 是一种非扩散性DR.这是一个开源的HCLSs.个性化医疗是个性化的医疗.增殖性DR (PDR) 是一种增殖性DR.更多相关视频
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
13.3K
07:41Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
Published on: October 23, 2020
5.7K
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
01:15Diabetes: Management and Pharmacotherapy
285
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
285
01:22Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
01:15Diabetes: Symptoms, Diagnosis, and Complications
544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
01:20Pathophysiology of Diabetes
937
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
937
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
201
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
201